Log In
BCIQ
Print this Print this
 

Healive

  Manage Alerts
Collapse Summary General Information
Company Sinovac Biotech Ltd.
DescriptionInactivated hepatitis A vaccine
Molecular Target Not applicable
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine
Latest Stage of DevelopmentMarketed
Standard IndicationHepatitis A virus (HAV)
Indication DetailsVaccinate against hepatitis A virus (HAV)
Regulatory Designation
PartnerBiolik Biopharmaceutical Co.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

$683.6M

$683.6M

0


 Deals Details
Get a free BioCentury trial today